Eduardo Augusto dos Santos Moreira Silva

Publications

243

Citations

H-Index

2021

Active since

Affiliations

McMaster University(Current)

Pontifícia Universidade Católica de Minas Gerais

Universidade Federal de Ouro Preto

Impact

Certara (United States)

Eduardo Augusto dos Santos Moreira Silva is an author at McMaster University specializing in covid-19 epidemiology, preventive medicine, and clinical trial design.

ORCID

Top concepts

Covid-19MedicineEpidemiologyPublic HealthClinical TrialsPharmacotherapyPopulation HealthPreventive MedicineClinical EpidemiologyClinical Trial Design

Publications per year

2021–2023

Publications

Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19

Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva et al. · JAMA Network Open · 2021 · 138 citations · Full text

RETRACTED: Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial

Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva et al. · The Lancet Regional Health - Americas · 2021 · 61 citations · Full text

Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19

Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva et al. · Annals of Internal Medicine · 2023 · 34 citations · Full text

A multi-center, adaptive, randomized, platform trial to evaluate the effect of repurposed medicines in outpatients with early coronavirus disease 2019 (COVID-19) and high-risk for complications: the TOGETHER master trial protocol

Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva et al. · Gates Open Research · 2021 · 10 citations · Full text

Repurposed Medicines, Population Health Sciences, Pharmacotherapy +17

Rows per page

1–4 of 4